GSK Plc (GSK)
54.44
-1.19
(-2.14%)
USD |
NYSE |
Apr 24, 16:00
54.42
-0.02
(-0.04%)
Pre-Market: 20:00
GSK EPS Diluted (Quarterly) : 0.414 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.743 |
| Biodexa Pharmaceuticals Plc | -- |
| Novavax, Inc. | 0.1061 |
| BioNTech SE | -1.448 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 966.83M |
| Revenue (Quarterly) | 11.46B |
| Total Expenses (Quarterly) | 10.62B |
| Enterprise Value | 127.46B |
| Gross Profit Margin (Quarterly) | 69.38% |
| Profit Margin (Quarterly) | 8.44% |
| Earnings Yield | 6.73% |
| Operating Earnings Yield | 8.70% |
| Normalized Earnings Yield | 7.265 |